Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8843907rdf:typepubmed:Citationlld:pubmed
pubmed-article:8843907lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0027540lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0443146lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8843907lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:8843907pubmed:issue11lld:pubmed
pubmed-article:8843907pubmed:dateCreated1996-11-6lld:pubmed
pubmed-article:8843907pubmed:abstractTextExperimental autoimmune uveoretinitis (EAU) serves as a model for several immune-mediated diseases that affect the eye in humans. Previous studies indicated that tumor necrosis factor alpha (TNF-alpha) has an important proinflammatory role in EAU and possibly in human uveitis. In this study, the authors investigated the effect of anti-TNF-alpha therapy on EAU in mice.lld:pubmed
pubmed-article:8843907pubmed:languageenglld:pubmed
pubmed-article:8843907pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:citationSubsetIMlld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8843907pubmed:statusMEDLINElld:pubmed
pubmed-article:8843907pubmed:monthOctlld:pubmed
pubmed-article:8843907pubmed:issn0146-0404lld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:ChanC CCClld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:WiggertBBlld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:SilverP BPBlld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:CaspiR RRRlld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:RizzoL VLVlld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:MastorakosGGlld:pubmed
pubmed-article:8843907pubmed:authorpubmed-author:SartaniGGlld:pubmed
pubmed-article:8843907pubmed:issnTypePrintlld:pubmed
pubmed-article:8843907pubmed:volume37lld:pubmed
pubmed-article:8843907pubmed:ownerNLMlld:pubmed
pubmed-article:8843907pubmed:authorsCompleteYlld:pubmed
pubmed-article:8843907pubmed:pagination2211-8lld:pubmed
pubmed-article:8843907pubmed:dateRevised2007-7-27lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:meshHeadingpubmed-meshheading:8843907-...lld:pubmed
pubmed-article:8843907pubmed:year1996lld:pubmed
pubmed-article:8843907pubmed:articleTitleAnti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.lld:pubmed
pubmed-article:8843907pubmed:affiliationLaboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.lld:pubmed
pubmed-article:8843907pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8843907lld:pubmed